An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
Clinical trial NCT03730961 · COMPLETED
Trial details
- NCT number
- NCT03730961
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2019-12-11
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.